rBCG-N-hRSV

N/A

Report date: 2023/06/01 20:00:46

Base Information

Drug NamerBCG-N-hRSV
Drug Alias NameEVA-VRS01
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryChile
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPontificia Universidad Catolica De Chile
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPontificia Universidad Catolica De Chile
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus Infections

Other Information

ATC CodeN/A
Related LinksN/A